 | • レポートコード：QYR2104Z1342 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）・がん幹細胞（CSC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞濃縮、検出、CTC分析）、用途別市場規模（病院、NSC、医学研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）の市場動向 ・企業の競争状況、市場シェア ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）の種類別市場規模（細胞濃縮、検出、CTC分析） ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）の用途別市場規模（病院、NSC、医学研究機関） ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）の北米市場規模2016-2027（アメリカ、カナダ） ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）の中南米市場規模2016-2027（メキシコ、ブラジル） ・循環腫瘍細胞（CTC）・がん幹細胞（CSC）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（QIAGEN Hannover、AVIVA Biosciences、Epic Sciences、ApoCell、Cynvenio Biosystems、Fluxion Biosciences、Rarecells、Janssen Diagnostics、CellTraffix、Silicon Biosystems、Advanced Cell Diagnostics） ・結論 |
The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the capacity of self-renewal. Cancer stem cells are the cancer cells that possess the characteristics of normal stem cells. Cancer stem cells are said to be responsible for relapse of cancers in patients. There is a growing interest in these two cell types due to their fundamental biological and clinical implications. Circulating tumor cells and cancer stem cells are an important element in order to understand cancer related mechanism and to find a cure from all type of cancers. These cells can be used for detecting of metastasis and the patients who are at a higher risk of cancer relapse.
The global circulating tumor cells and cancer stem cells market is anticipated to grow at a rapid rate owing to development in biotechnology and biomedical engineering. According to WHO, Cancer is the leading cause of mortality and morbidity globally impacting about 14 million people annually, leading to rapid increase in research activities worldwide. Circulating tumor cells and cancer stem cells are under research for various types of cancer such as breast cancer, lung cancer, colorectal cancer, skin cancer. Government and various government bodies are taking interest and initiative to boost funds and activities which is one of the major factor driving the growth of the global circulating tumor cells and cancer stem cells market.
Market Analysis and Insights: Global Circulating Tumor Cells and Cancer Stem Cells Market
The global Circulating Tumor Cells and Cancer Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Circulating Tumor Cells and Cancer Stem Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Circulating Tumor Cells and Cancer Stem Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Circulating Tumor Cells and Cancer Stem Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Circulating Tumor Cells and Cancer Stem Cells market.
Global Circulating Tumor Cells and Cancer Stem Cells Scope and Market Size
Circulating Tumor Cells and Cancer Stem Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells and Cancer Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cell Enrichment
Detection
CTC Analysis
Segment by Application
Hospital
NSC
Medical Research Institute
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
QIAGEN Hannover
AVIVA Biosciences
Epic Sciences
ApoCell
Cynvenio Biosystems
Fluxion Biosciences
Rarecells
Janssen Diagnostics
CellTraffix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Enrichment
1.2.3 Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 NSC
1.3.4 Medical Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Perspective (2016-2027)
2.2 Circulating Tumor Cells and Cancer Stem Cells Growth Trends by Regions
2.2.1 Circulating Tumor Cells and Cancer Stem Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Circulating Tumor Cells and Cancer Stem Cells Historic Market Share by Regions (2016-2021)
2.2.3 Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Regions (2022-2027)
2.3 Circulating Tumor Cells and Cancer Stem Cells Industry Dynamic
2.3.1 Circulating Tumor Cells and Cancer Stem Cells Market Trends
2.3.2 Circulating Tumor Cells and Cancer Stem Cells Market Drivers
2.3.3 Circulating Tumor Cells and Cancer Stem Cells Market Challenges
2.3.4 Circulating Tumor Cells and Cancer Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Revenue
3.1.1 Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Revenue (2016-2021)
3.1.2 Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Players (2016-2021)
3.2 Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells and Cancer Stem Cells Revenue
3.4 Global Circulating Tumor Cells and Cancer Stem Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2020
3.5 Circulating Tumor Cells and Cancer Stem Cells Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells and Cancer Stem Cells Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells and Cancer Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells and Cancer Stem Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells and Cancer Stem Cells Historic Market Size by Type (2016-2021)
4.2 Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Type (2022-2027)
5 Circulating Tumor Cells and Cancer Stem Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells and Cancer Stem Cells Historic Market Size by Application (2016-2021)
5.2 Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Circulating Tumor Cells and Cancer Stem Cells Market Size (2016-2027)
6.2 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type
6.2.1 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021)
6.2.2 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027)
6.2.3 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2027)
6.3 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application
6.3.1 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021)
6.3.2 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027)
6.3.3 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2027)
6.4 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country
6.4.1 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021)
6.4.2 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size (2016-2027)
7.2 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type
7.2.1 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021)
7.2.2 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027)
7.2.3 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2027)
7.3 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application
7.3.1 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021)
7.3.2 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027)
7.3.3 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2027)
7.4 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country
7.4.1 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021)
7.4.2 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size (2016-2027)
8.2 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size (2016-2027)
9.2 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type
9.2.1 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021)
9.2.2 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027)
9.2.3 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2027)
9.3 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application
9.3.1 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021)
9.3.2 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027)
9.3.3 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2027)
9.4 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country
9.4.1 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021)
9.4.2 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size (2016-2027)
10.2 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 QIAGEN Hannover
11.1.1 QIAGEN Hannover Company Details
11.1.2 QIAGEN Hannover Business Overview
11.1.3 QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Introduction
11.1.4 QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.1.5 QIAGEN Hannover Recent Development
11.2 AVIVA Biosciences
11.2.1 AVIVA Biosciences Company Details
11.2.2 AVIVA Biosciences Business Overview
11.2.3 AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Introduction
11.2.4 AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.2.5 AVIVA Biosciences Recent Development
11.3 Epic Sciences
11.3.1 Epic Sciences Company Details
11.3.2 Epic Sciences Business Overview
11.3.3 Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Introduction
11.3.4 Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.3.5 Epic Sciences Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells and Cancer Stem Cells Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.4.5 ApoCell Recent Development
11.5 Cynvenio Biosystems
11.5.1 Cynvenio Biosystems Company Details
11.5.2 Cynvenio Biosystems Business Overview
11.5.3 Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Introduction
11.5.4 Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.5.5 Cynvenio Biosystems Recent Development
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Details
11.6.2 Fluxion Biosciences Business Overview
11.6.3 Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Introduction
11.6.4 Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.6.5 Fluxion Biosciences Recent Development
11.7 Rarecells
11.7.1 Rarecells Company Details
11.7.2 Rarecells Business Overview
11.7.3 Rarecells Circulating Tumor Cells and Cancer Stem Cells Introduction
11.7.4 Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.7.5 Rarecells Recent Development
11.8 Janssen Diagnostics
11.8.1 Janssen Diagnostics Company Details
11.8.2 Janssen Diagnostics Business Overview
11.8.3 Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Introduction
11.8.4 Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.8.5 Janssen Diagnostics Recent Development
11.9 CellTraffix
11.9.1 CellTraffix Company Details
11.9.2 CellTraffix Business Overview
11.9.3 CellTraffix Circulating Tumor Cells and Cancer Stem Cells Introduction
11.9.4 CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.9.5 CellTraffix Recent Development
11.10 Silicon Biosystems
11.10.1 Silicon Biosystems Company Details
11.10.2 Silicon Biosystems Business Overview
11.10.3 Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Introduction
11.10.4 Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.10.5 Silicon Biosystems Recent Development
11.11 Advanced Cell Diagnostics
11.11.1 Advanced Cell Diagnostics Company Details
11.11.2 Advanced Cell Diagnostics Business Overview
11.11.3 Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Introduction
11.11.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
11.11.5 Advanced Cell Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Enrichment
Table 3. Key Players of Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions (2016-2021)
Table 9. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions (2022-2027)
Table 11. Circulating Tumor Cells and Cancer Stem Cells Market Trends
Table 12. Circulating Tumor Cells and Cancer Stem Cells Market Drivers
Table 13. Circulating Tumor Cells and Cancer Stem Cells Market Challenges
Table 14. Circulating Tumor Cells and Cancer Stem Cells Market Restraints
Table 15. Global Circulating Tumor Cells and Cancer Stem Cells Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players (2016-2021)
Table 17. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2020)
Table 18. Ranking of Global Top Circulating Tumor Cells and Cancer Stem Cells Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Circulating Tumor Cells and Cancer Stem Cells Product Solution and Service
Table 22. Date of Enter into Circulating Tumor Cells and Cancer Stem Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2016-2021)
Table 26. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Application (2016-2021)
Table 30. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 62. QIAGEN Hannover Company Details
Table 63. QIAGEN Hannover Business Overview
Table 64. QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Product
Table 65. QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 66. QIAGEN Hannover Recent Development
Table 67. AVIVA Biosciences Company Details
Table 68. AVIVA Biosciences Business Overview
Table 69. AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Product
Table 70. AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 71. AVIVA Biosciences Recent Development
Table 72. Epic Sciences Company Details
Table 73. Epic Sciences Business Overview
Table 74. Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Product
Table 75. Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 76. Epic Sciences Recent Development
Table 77. ApoCell Company Details
Table 78. ApoCell Business Overview
Table 79. ApoCell Circulating Tumor Cells and Cancer Stem Cells Product
Table 80. ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 81. ApoCell Recent Development
Table 82. Cynvenio Biosystems Company Details
Table 83. Cynvenio Biosystems Business Overview
Table 84. Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Product
Table 85. Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 86. Cynvenio Biosystems Recent Development
Table 87. Fluxion Biosciences Company Details
Table 88. Fluxion Biosciences Business Overview
Table 89. Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Product
Table 90. Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 91. Fluxion Biosciences Recent Development
Table 92. Rarecells Company Details
Table 93. Rarecells Business Overview
Table 94. Rarecells Circulating Tumor Cells and Cancer Stem Cells Product
Table 95. Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 96. Rarecells Recent Development
Table 97. Janssen Diagnostics Company Details
Table 98. Janssen Diagnostics Business Overview
Table 99. Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 100. Janssen Diagnostics Recent Development
Table 101. CellTraffix Company Details
Table 102. CellTraffix Business Overview
Table 103. CellTraffix Circulating Tumor Cells and Cancer Stem Cells Product
Table 104. CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 105. CellTraffix Recent Development
Table 106. Silicon Biosystems Company Details
Table 107. Silicon Biosystems Business Overview
Table 108. Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Product
Table 109. Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 110. Silicon Biosystems Recent Development
Table 111. Advanced Cell Diagnostics Company Details
Table 112. Advanced Cell Diagnostics Business Overview
Table 113. Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product
Table 114. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 115. Advanced Cell Diagnostics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Type: 2020 VS 2027
Figure 2. Cell Enrichment Features
Figure 3. Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. NSC Case Studies
Figure 8. Medical Research Institute Case Studies
Figure 9. Circulating Tumor Cells and Cancer Stem Cells Report Years Considered
Figure 10. Global Circulating Tumor Cells and Cancer Stem Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Circulating Tumor Cells and Cancer Stem Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions: 2020 VS 2027
Figure 13. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions (2022-2027)
Figure 14. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players in 2020
Figure 15. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2020
Figure 17. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2016-2021)
Figure 18. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2022-2027)
Figure 19. North America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2016-2027)
Figure 21. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2016-2027)
Figure 22. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2016-2027)
Figure 23. United States Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2016-2027)
Figure 27. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2016-2027)
Figure 28. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2016-2027)
Figure 29. Germany Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2016-2027)
Figure 39. China Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2016-2027)
Figure 47. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2016-2027)
Figure 48. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2016-2027)
Figure 49. Mexico Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2016-2027)
Figure 55. Turkey Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. QIAGEN Hannover Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 59. AVIVA Biosciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 60. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 61. ApoCell Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 62. Cynvenio Biosystems Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 63. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 64. Rarecells Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 65. Janssen Diagnostics Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 66. CellTraffix Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 67. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 68. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation. Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasi…
- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
- 世界のがん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. Over the past few years, stem cells are being successf…
- 世界の上皮幹細胞市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Epithelial Stem Cells Market The global Epithelial Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…